Transas Middle East to Re-Equip JAMS with New Maritime …

first_img My location Transas Middle East, December 17, 2013; Image: Wikimapia 此页面无法正确加载 Google 地图。您是否拥有此网站?确定 zoom Transas Middle East has won a contract to re-equip and expand Jordan Academy for Maritime Studies (JAMS) with new maritime simulators.The project includes relocation of existing navigational simulator NTPRO 5000 and Transas GMDSS Simulator 4000 (TGS 4000) Classroom and installation of the latest generation of the Transas Full Mission Ship Simulator NTPRO 5000 with 240 degree visualisation and real ship controls.The Transas NTPRO 5000 navigational simulator boasts visualisation system which offers the highest level of realism featuring wind-generated sea state and variable swell model with user-selected sea state spectrum, accurate vessel and wave interaction, full scene and environment reflection, and 3D bow waves and propeller wash, and associated floating object interference. New grounding, synchronous rolling, broaching and other modeling features make training close to reality. Integrated VHF, Intercom solutions, and voice communication are available for debrief and assessment. The new Full mission Ship Handling Simulator will provide opportunity for bridge team management training, including SAR operations. Print Closelast_img read more

Canada prepares for drug patent concessions to clinch freetrade deal with EU

by Heather Scoffield, The Canadian Press Posted Nov 13, 2012 6:23 pm MDT AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to RedditRedditShare to 電子郵件Email Canada prepares for drug patent concessions to clinch free-trade deal with EU OTTAWA – As free trade talks with the European Union reach the endgame, Ottawa is signalling it is prepared to give the Europeans at least part of what they asked for on drug patents — a move that could cost Canadians up to $900 million a year.With negotiations at the bureaucratic level nearing closure, International Trade Minister Ed Fast will meet his European counterpart in Brussels next week, taking the discussions to the next level.He and Agriculture Minister Gerry Ritz hope to hammer out the most contentious details of the agreement in hopes of bringing it to a close in the coming weeks — although both Canada and Europe are indicating that discussions will likely drag on into the new year.“The things that are really difficult are being saved till the end,” said John Weekes, a trade consultant who was the chief negotiator for NAFTA and who is now advising the generic drug industry.“The presence of the ministers will create a different dynamic.”At the same time, the government has launched a public relations blitz in Canada designed to convince Canadians that the free-trade deal with Europe will mean better sales of “iconic” Canadian goods such as maple syrup and Tilley hats, and bring in benefits to the tune of $1,000 extra per family per year.But the PR exercise is not going anywhere near the intellectual property issue that has clouded the talks from Day 1.Government and industry sources say Fast is willing to give the EU somewhat stiffer patent protection for brand-name pharmaceuticals, despite intense pressure from the generic drug industry in Canada, health care advocates as well as several provincial governments who don’t want to see their drug costs rise.But government officials are also warning that it’s not over until the fat lady sings, since the final rounds of any trade negotiation are full of give and take — and drug patents are right in the centre of that dynamic.“Negotiations are continuing and the negotiating teams are engaged in focused discussions on the remaining issues, covering a wide range,” said Adam Taylor, a spokesman for Fast.“Speculation on any final outcomes would be precisely that — inaccurate speculation.”Isabelle Robillard, the spokesperson for Canada’s Research-based Pharmaceutical Companies, refused to comment while the talks are still ongoing, although sources say the brand-name industry is quietly celebrating victory.The generic drug industry, meanwhile, is not admitting defeat.“We’re still hopeful,” said Jim Keon, president of the Canadian Generic Pharmaceutical Association. “We haven’t been told of any final decision.”NDP trade critic Don Davies said increased patent protection wouldn’t necessarily be a deal-breaker for the official Opposition. The NDP will wait to see the final agreement in its entirety and weigh the overall pros and cons before taking a position on it.Still, Davies said it seems a “curious” negotiating strategy to telegraph Canada’s willingness to cave on drug patents. And it underscores the danger involved in negotiating trade deals behind closed doors with no public input.“I do think that Canadians need to know that the Conservatives are pursuing, under the guise of trade policy, they’re including many other policies that I think Canadians wouldn’t support if they weren’t buried in a trade deal,” he said.An internal government calculation of the effect of stiffer brand-name patent protection pegs the cost at between $367 million and $903 million a year, since longer patents mean provincial governments, employers and consumers will wind up buying brand-name drugs for a longer period rather than cheaper generics.But it could be worse. A full concession to EU demands on patent-term restoration would extend brand-name patents by an average of 2.66 years, and cost Canadians between $795 million and $2 billion a year, according to government calculations obtained last month by The Canadian Press.Sources say Ottawa is not willing to go that far, but could settle for a more moderate version of the EU demands.“It wouldn’t surprise me at all, because that’s the trajectory we’re heading down anyway,” said Ottawa-based international trade consultant Laura Dawson.Brand-name pharmaceutical companies, with head offices mainly based in Europe, have long been at war with the generic industry in Canada, lobbying constantly for changes in the drug patent regime that would tilt regulations in their favour.In the European trade talks, the EU has put forward three demands on drug patents: patent term restoration to make up for the time brand-name drugs wait for regulatory approval; 10 years of data exclusivity, instead of eight; and beefed-up legal rights for brand names to appeal patent decisions.Europe and the brand-name industry have argued that Canada’s patent regime is below international standards — an argument echoed by the United States and many within Canada’s business community.And even the generic drug industry is willing to entertain a change in the avenues for legal appeals, if it means making a more coherent system for an industry known for its litigious nature.Canada has not been willing to discuss any of the demands until now — leaving one of the most contentious agenda items until the very end of the talks.Now, federal officials are under intense pressure to deliver a final deal, said Dawson. And since ceding ground on pharmaceutical patents will probably be demanded of Canada in upcoming trade talks with Pacific nations anyway, a partial concession with Europe — in return for something else — seems like a wise move.“Canada is really feeling a lot of pressure to conclude this agreement,” Dawson said. “The Canadians are sweating.”It’s not clear what Canada would get in return, although better access to European markets for Canadian beef and pork is likely on its list of possibilities.The federal government says the trade agreement with the EU would boost bilateral trade by 20 per cent, and add $12 billion a year to Canada’s economy — gains that translate to an average of $1000 a year per family, or 80,000 new jobs. read more

Belgians seeking 2 new suspects in Paris attacks probe who used false

by Lorne Cook And John-Thor Dahlburg, The Associated Press Posted Dec 3, 2015 4:57 am MDT Last Updated Dec 4, 2015 at 11:20 am MDT AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to RedditRedditShare to 電子郵件Email Audrey Bily, right, and Romain Debray, managers of La Bonne Biere, speak to the media in front of their cafe in Paris during its reopening Friday, Dec. 4, 2015. The cafe where five people were killed by a squad of Islamic extremist gunmen on Nov. 13, terrorizing central Paris reopened for business Friday. (AP Photo/Jacques Brinon) Belgians seeking 2 new suspects in Paris attacks probe who used false IDs around Europe BRUSSELS – Belgian and French authorities were hunting two new suspects Friday in the Paris attacks who they say used fake identity cards around Europe and sent money to a relative of the man who orchestrated the attacks the day before the ringleader died in a shootout with French police.The two men, carrying bogus ID in the names of Samir Bouzid and Soufiane Kayal, had been travelling in a Mercedes with another Paris attacks fugitive, Salah Abdeslam, when the car was checked Sept. 9 at the Hungarian-Austrian border, the Belgian Federal Prosecutor’s office said in a statement Friday.The same Kayal ID was used to rent a house in the Belgian town of Auvelais that authorities have searched as a possible site for making the suicide bombs used in the Nov. 13 Paris attacks, the prosecutor’s office said.The Islamic State group has claimed responsibility for those gun-and-bomb attacks that killed 130 people and wounded hundreds in Paris.Belgian authorities said about 6 p.m. on Nov. 17, four days after the Paris attacks, the false identity card in the name of Bouzid was used at a Western Union office in the Brussels area to send a 750-euro ($817) money order to Hasna Ait Boulhacen, cousin of the purported attack ringleader, Abdelhamid Abaaoud.Both Boulhacen and Abaaoud died a day later when French police stormed their hideout in a Paris suburb.The two new suspects “are being actively sought by Belgian and French police services,” the prosecutor’s office said.Spurred into action by the Paris attacks, the interior ministers of the European Union moved Friday to grant law-enforcement agencies access to information gathered by airlines — data like passengers’ names, travel dates, itinerary, credit cards and contact details.The sharing of such data is meant to allow better scrutiny of known or suspected extremists.Under the passenger data deal, details would be collected from European carrier flights entering or leaving the EU, as well as from flights between member countries. Charter flights will be included, and all the information will be kept on file for six months.Luxembourg Deputy Prime Minister Etienne Schneider, who chaired the meeting in Brussels, expressed his “pride that after so many years of negotiations, we have now been able to conclude an agreement.”The passenger record agreement proposal was first made in 2007, but it languished in the European Parliament for years as EU lawmakers struggled to strike the right balance between security concerns and privacy rights. The assembly must still endorse the deal but that is likely to happen within the next month.At least 5,000 Europeans are believed to have trained or fought in Syria and Iraq but authorities are struggling to track their movements and prove their activities. French Interior Minister Bernard Cazeneuve described the new system as “indispensable in the fight against terrorism.”The EU already has such passenger data deals with the U.S., Canada and Australia.In Paris, patrons began returning as La Bonne Biere, a corner cafe in the trendy central district targeted by the gunmen, reopened Friday.Since the attacks, the shuttered cafe has been piled high with flowers. Paule Zlotnik, a neighbouring shopkeeper, praised the decision to reopen.“It’s time they open and that we continue life as it was before,” he said.In surveillance video seen by The Associated Press, two gunmen in black calmly approached La Bonne Biere on the night of Nov. 13, firing deliberately on its outdoor tables before turning back toward a car rolling slowly behind them. read more